Collectively, our high content analysis data demonstrate that TP53 wild-type glioblastoma cell lines are similarly sensitive to RG7112 and AMG232, while TP53 mutant glioblastoma cell lines are insensitive to the drugs. This evidence concerns the gene TP53 and glioblastoma.